Selective blockade of androgenic steroid synthesis b... [BJU Int. 2005] - PubMed

loading

Expanding treatment options for metastatic prostate cancer. [N Engl J Med. 2011]
Expanding treatment options for metastatic prostate cancer.
Antonarakis ES, Eisenberger MA. N Engl J Med. 2011 May 26; 364(21):2055-8.
Review Novel concepts in androgen receptor blockade. [Cancer J. 2008]
Review Novel concepts in androgen receptor blockade.
Hsieh AC, Ryan CJ. Cancer J. 2008 Jan-Feb; 14(1):11-4.
Abiraterone and increased survival in metastatic prostate cancer. [N Engl J Med. 2011]
Abiraterone and increased survival in metastatic prostate cancer.
Sonpavde G. N Engl J Med. 2011 Aug 25; 365(8):766-7; author reply 767-8.
Abiraterone and increased survival in metastatic prostate cancer. [N Engl J Med. 2011]
Abiraterone and increased survival in metastatic prostate cancer.
Berruti A, Pia A, Terzolo M. N Engl J Med. 2011 Aug 25; 365(8):766; author reply 767-8.
Review Inhibition of p450 17 as a new strategy for the treatment of prostate cancer. [Curr Med Chem. 2005]
Review Inhibition of p450 17 as a new strategy for the treatment of prostate cancer.
Leroux F. Curr Med Chem. 2005; 12(14):1623-9.

The changing landscape in the treatment of metastatic castration-resistant prostate cancer. [Ther Adv Med Oncol. 2013]
The changing landscape in the treatment of metastatic castration-resistant prostate cancer.
El-Amm J, Aragon-Ching JB. Ther Adv Med Oncol. 2013 Jan; 5(1):25-40.
Clinical appraisal of abiraterone in the treatment of metastatic prostatic cancer: patient considerations, novel opportunities, and future directions. [Onco Targets Ther. 2013]
Clinical appraisal of abiraterone in the treatment of metastatic prostatic cancer: patient considerations, novel opportunities, and future directions.
Bedoya DJ, Mitsiades N. Onco Targets Ther. 2013; 6:9-18. Epub 2013 Jan 3.
Castration-resistant prostate cancer: mechanisms, targets, and treatment. [Prostate Cancer. 2012]
Castration-resistant prostate cancer: mechanisms, targets, and treatment.
Amaral TM, Macedo D, Fernandes I, Costa L. Prostate Cancer. 2012; 2012:327253. Epub 2012 Mar 5.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Selective blockade of androgenic steroid synthesis by novel lyase inhibitors as ...
Selective blockade of androgenic steroid synthesis by novel lyase inhibitors as a therapeutic strategy for treating metastatic prostate cancer.
BJU Int. 2005 Dec ;96(9):1241-6.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed